bevacizumab

Ligand id: 6771

Name: bevacizumab

References
1. Baca M, Chen Y M-Y, Lowman HB, Presta LG, Wells JA. (1998)
Anti-vegf antibodies.
Patent number: WO1998045331. Assignee: Genentech Inc,. Priority date: 07/04/1997. Publication date: 15/10/1998.
2. Glade-Bender J, Kandel JJ, Yamashiro DJ. (2003)
VEGF blocking therapy in the treatment of cancer.
Expert Opin Biol Ther3 (2): 263-76. [PMID:12662141]
3. Yang JC, Haworth L, Sherry RM, Hwu P, Schwartzentruber DJ, Topalian SL, Steinberg SM, Chen HX, Rosenberg SA. (2003)
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.
N. Engl. J. Med.349 (5): 427-34. [PMID:12890841]